Evidence map›Paper›PMID 23753091›Full record

Trial reportPediatrics2013

The RIVUR trial: profile and baseline clinical associations of children with vesicoureteral reflux.

Myra A Carpenter, Alejandro Hoberman, Tej K Mattoo, Ranjiv Mathews, Ron Keren, Russell W Chesney, Marva Moxey-Mims, Saul P Greenfield, RIVUR Trial Investigators

Registry-linked trialOpen access · greenAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Pediatrics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00405704 (Randomized Intervention for Children With Vesicoureteral Reflux), which is not on this map. Cited by 29 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 2 pooled it
16.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00405704 phase3completednot on this map

Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR)

TypeinterventionalSponsorNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Ran2007 to 2014Enrolled607ConditionsVesicoureteral Reflux, Urinary Tract InfectionsArmsTrimethoprim-Sulfamethoxazole, Placebo
3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 2 syntheses or guidelines pooled it, 89 citations in OpenAlex.

  1. Pooled it
  2. Interventions for primary vesicoureteric reflux.The Cochrane database of systematic reviews · 2019
    Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Renal Scarring in the Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial.Clinical journal of the American Society of Nephrology : CJASN · 2016
    Trial
  8. Trial
  9. Trial
  10. Article
  11. Article
  12. Article
  13. Long-term consequences of urinary tract infection in childhood: an electronic population-based cohort study in Welsh primary and secondary care.The British journal of general practice : the journal of the Royal College of General Practitioners · 2024
    Article
  14. Article
  15. Review
  16. Article
  17. [Long-term prognosis of vesicoureteral reflux: a follow-up observation of 138 children].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2019
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 8 institutions in 1 country.

Myra A CarpenterDepartment of Biostatistics, The University of North Carolina, Chapel Hill, NC, USA. myra.carpenter@unc.edu
Alejandro Hoberman
Tej K Mattoo
Ranjiv Mathews
Ron Keren
Russell W Chesney
Marva Moxey-Mims
Saul P Greenfield
RIVUR Trial Investigators
Children's Hospital of Michigan · USChildren's Hospital of Philadelphia · USChildren's Hospital of Pittsburgh · USJohns Hopkins University · USNational Institutes of Health · USUniversity of North Carolina at Chapel Hill · USUniversity of Tennessee Health Science Center · USWomen & Children's Hospital of Buffalo · US

Funding

University of Pittsburgh Clinical and Translational Science InstituteUL1TR000005 · NCATS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2012 to 2015
$50.8M
Institutional Clinical and Translational Science AwardUL1TR000003 · NCATS · UNIVERSITY OF PENNSYLVANIA · PI FITZGERALD, GARRET A · 2012 to 2015
$38.9M
Oregon Clinical and Translational Research InstituteUL1TR000128 · NCATS · OREGON HEALTH & SCIENCE UNIVERSITY · PI ELLISON, DAVID H · 2012 to 2015
$28.7M
Randomized Intervention for Vesicoureteral Reflux (RIVUR)U01DK074059 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI CARPENTER, MYRA A. · 2005 to 2012
$11.3M
POET Study: Clinical Trial of Girls with RefluxU01DK074063 · NIDDK · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI GREENFIELD, SAUL PHILIP · 2005 to 2012
$5.0M
RIVUR - Randomized Intervention for Children with Vesicoureteral RefluxU01DK074053 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI HOBERMAN, ALEJANDRO · 2005 to 2012
$4.3M
RIVUR StudyU01DK074062 · NIDDK · WAYNE STATE UNIVERSITY · PI MATTOO, TEJ K · 2005 to 2012
$4.0M
Randomized Intervention for VesicolUreteral Reflux (RIVUR) StudyU01DK074064 · NIDDK · CHILDREN'S HOSP OF PHILADELPHIA · PI KEREN, RON · 2005 to 2012
$2.8M
Randomized Intervention for Vesico-Ureteral Reflux (RIVUR) TrialU01DK074082 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI WANG, MING-HSIEN · 2005 to 2012
$2.5M
Clinical Outcomes for Siblings of Children with Vesico-Ureteral RefluxK23DK088943 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI NELSON, CALEB PENNELL · 2010 to 2014
$892k
NCATS NIH HHS UL1 TR000003NCATS NIH HHS UL1TR000003NCATS NIH HHS UL1 TR000005NCATS NIH HHS UL1 TR000128NIDDK NIH HHS K23 DK088943NIDDK NIH HHS U01 DK074053NIDDK NIH HHS U01 DK074059NIDDK NIH HHS U01 DK074062NIDDK NIH HHS U01 DK074063NIDDK NIH HHS U01 DK074064NIDDK NIH HHS U01 DK074082
6 · The paper itself

Abstract

BACKGROUND AND

objectiveVesicoureteral reflux (VUR) is diagnosed in ∼30% to 40% of children who have imaging studies after urinary tract infections (UTIs). Our goal is to characterize children enrolled in the Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) trial and to compare our study cohort with those from previously published studies.

methodsRIVUR investigators from 19 pediatric sites in the United States recruited 607 children with grade I through IV VUR. Children were enrolled after a first or second UTI. This cross-sectional report of baseline data includes extensive clinical, parental report, and imaging study results.

resultsRIVUR recruited 607 children (558 girls, 49 boys) with grade I (11%), II (42%), III (38%), or IV (8%) reflux. The median age was 12 months, and most children (91%) were enrolled after their first UTI. The UTI leading to enrollment was both febrile and symptomatic for 323 children, febrile only in 197 children, and symptomatic only in 86. Renal involvement at baseline as documented by a (99m)Tc dimercaptosuccinic acid scan was uncommon with cortical defects identified in 89 (15%) children. Bladder and bowel dysfunction was identified in 71 (56%) of 126 toilet-trained subjects assessed.

conclusionsRIVUR is the largest prospective, randomized trial for children with primary VUR to date, comparing prophylaxis with placebo. The study sample comprises patients from 19 pediatric clinical sites in the United States, whose demographic and clinical characteristics may differ from those of children enrolled in previous trials from other countries.

Indexed as

Anti-Infective Agents, UrinaryChild, PreschoolCohort StudiesCross-Sectional StudiesDouble-Blind MethodFemaleHumansInfantKidney CortexLong-Term CareMaleMass ScreeningPatient SelectionProspective StudiesSecondary PreventionTechnetium Tc 99m Dimercaptosuccinic AcidAnti-Infective Agents, UrinaryTechnetium Tc 99m Dimercaptosuccinic AcidTrimethoprim, Sulfamethoxazole Drug Combinationclinical research/trialsrenal scarringurinary tract infectionsvesicoureteral reflux (VUR)

Identifiers

PMID23753091
PMCPMC3691529
OpenAlexW2068406686

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.